Bogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic
NIKITIN, A.G.,
CHUDAKOVA, D.A.,
ENIKEEV, R.F.,
GORDIEV, M.G.,
SAKAEVA, D.,
DRUZHKOV, M.,
SHIGAPOVA, L.H.,
BROVKINA, O.I.,
SHAGIMARDANOVA, E.I.,
GUSEV, O.A. (2020) proposed that Lynch Syndrome-related germline mutations (LS-mutations) are associated with
breast cancerLarionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) to
cancer therapy in patients with five aggressive types of
cancer:
breast, colorectal, lung, ovarian
FACHAL, L.,
KAR, S.,
TYRER, J.P.,
GHOUSSAINI, M.,
HARRINGTON, P.A.,
HEALEY, C.S.,
MAYES, R.,
SHAH, M.,
PHAROAH, P.D.P.,
EASTON, D.F.,
DUNNING, A.M.,
ASCHARD, H.,
JIANG, X.,
TAMIMI, R.M.,
KHUSNUTDINOVA, E.,
BIAŁKOWSKA, K.,
и др. соавторы (2020) Genome-wide association studies have identified
breast cancer risk variants in over 150 genomic
Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial
, such as hormone-insensitive
breast cancer and prostate
cancer, cholangiocarcinoma, and multiple myeloma
Despite many advances in diagnosis and therapy (surgery, radiation therapy, chemotherapy),
cancer